• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型口蹄疫病毒 Asia 1 型多表位疫苗在豚鼠和绵羊中的免疫潜力。

Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

机构信息

College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, China.

出版信息

Virol Sin. 2011 Jun;26(3):190-7. doi: 10.1007/s12250-011-3174-0. Epub 2011 Jun 12.

DOI:10.1007/s12250-011-3174-0
PMID:21667339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8222439/
Abstract

To develop a safe and efficient recombinant subunit vaccine to foot-and-mouth disease virus (FMDV) type Asia 1 in sheep, a tandem repeated multiple-epitope gene consisting of residues 137-160 and 197-211 of the VP1 gene of FMDV was designed and artificially synthesized. The biologically functional molecule, the ovine IgG heavy constant region (oIgG) as a protein carrier was introduced for design of the multiple-epitope recombinant vaccine and recombinant expression plasmids pET-30a-RE and pET-30a-RE-oIgG were successfully constructed. The recombinant proteins, RE and RE-oIgG, were expressed as a formation of inclusion bodies in E. coli. The immune potential of this vaccine regime in guinea pigs and sheep was evaluated. The results showed that IgG could significantly enhance the immune potential of antigenic epitopes. The recombinant protein RE-oIgG could not only elicit the high levels of neutralizing antibodies and lymphocytes proliferation responses in the vaccinated guinea pigs, but confer complete protection in guinea pigs against virus challenge. Although the recombinant protein RE could not confer protection in the vaccinated animals, it could delay the appearance of the clinical signs and reduce the severity of disease. Inspiringly, the titers of anti-FMDV neutralizing antibodies elicited in sheep vaccinated with RE-oIgG was significantly higher than that for the RE vaccination. Therefore, we speculated that this vaccine formulation may be a promising strategy for designing a novel vaccine against FMDV in the future.

摘要

为了开发一种安全有效的绵羊口蹄疫病毒(FMDV)亚洲 1 型重组亚单位疫苗,设计并人工合成了串联重复的多表位基因,该基因由 FMDV VP1 基因的 137-160 位和 197-211 位残基组成。为了设计多表位重组疫苗,引入了具有生物功能的分子——绵羊 IgG 重恒定区(oIgG)作为蛋白质载体,并成功构建了重组表达质粒 pET-30a-RE 和 pET-30a-RE-oIgG。重组蛋白 RE 和 RE-oIgG 在大肠杆菌中以包涵体的形式表达。在豚鼠和绵羊中评估了这种疫苗方案的免疫潜力。结果表明,IgG 可以显著增强抗原表位的免疫潜力。重组蛋白 RE-oIgG 不仅能在接种豚鼠中引起高水平的中和抗体和淋巴细胞增殖反应,还能完全保护豚鼠免受病毒攻击。虽然重组蛋白 RE 不能在接种动物中提供保护,但它可以延迟临床症状的出现并减轻疾病的严重程度。令人鼓舞的是,用 RE-oIgG 接种的绵羊产生的抗 FMDV 中和抗体滴度明显高于 RE 接种的绵羊。因此,我们推测这种疫苗配方可能是未来设计 FMDV 新型疫苗的有前途的策略。

相似文献

1
Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.新型口蹄疫病毒 Asia 1 型多表位疫苗在豚鼠和绵羊中的免疫潜力。
Virol Sin. 2011 Jun;26(3):190-7. doi: 10.1007/s12250-011-3174-0. Epub 2011 Jun 12.
2
Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.有望用于猪的抗O型口蹄疫病毒的多表位重组疫苗。
Clin Vaccine Immunol. 2011 Jan;18(1):143-9. doi: 10.1128/CVI.00236-10. Epub 2010 Nov 17.
3
Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.基于辛德毕斯病毒复制酶的 DNA 疫苗构建体,编码口蹄疫病毒特异性多价表位基因:在豚鼠中的免疫应答研究。
Scand J Immunol. 2012 Oct;76(4):345-53. doi: 10.1111/j.1365-3083.2012.02733.x.
4
A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs.猪口蹄疫病毒血清型 O 的一种重组多表位三价疫苗。
Virology. 2024 Aug;596:110103. doi: 10.1016/j.virol.2024.110103. Epub 2024 May 10.
5
Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.牛 O 型口蹄疫病毒重组表位疫苗的效力与结构相关性。
Biotechnol Lett. 2012 May;34(5):839-47. doi: 10.1007/s10529-012-0856-0.
6
[Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].[针对A型口蹄疫的合成肽疫苗评估]
Wei Sheng Wu Xue Bao. 2013 Jun 4;53(6):596-607.
7
Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.用毕赤酵母表达的重组P1多聚蛋白免疫的豚鼠针对口蹄疫病毒攻击的保护性免疫反应
Arch Virol. 2005 May;150(5):967-79. doi: 10.1007/s00705-004-0460-2. Epub 2005 Jan 19.
8
Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.口服表达口蹄疫病毒多表位和霍乱毒素 B 亚单位的重组枯草芽孢杆菌的免疫应答。
J Virol Methods. 2011 Jan;171(1):272-9. doi: 10.1016/j.jviromet.2010.11.023. Epub 2010 Dec 1.
9
Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.水疱性口炎病毒糖蛋白 G 携带口蹄疫病毒抗原位点 A 的串联二聚体可作为牛的 DNA 和肽疫苗使用。
Antiviral Res. 2011 Nov;92(2):219-27. doi: 10.1016/j.antiviral.2011.08.006. Epub 2011 Aug 26.
10
Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.高免疫原性 O1 曼萨那单价疫苗对绵羊感染 O/SEA/Mya-98 谱系口蹄疫病毒的效力。
Antiviral Res. 2017 Sep;145:114-122. doi: 10.1016/j.antiviral.2017.07.020. Epub 2017 Aug 3.

引用本文的文献

1
Evaluation of vaccine efficacy with 2B/T epitope conjugated porcine IgG-Fc recombinants against foot-and-mouth disease virus.评估 2B/T 表位缀合猪 IgG-Fc 重组蛋白对口蹄疫病毒的疫苗效力。
J Vet Med Sci. 2024 Sep 20;86(9):999-1007. doi: 10.1292/jvms.23-0480. Epub 2024 Jul 29.
2
Designing Functionally Versatile, Highly Immunogenic Peptide-Based Multiepitopic Vaccines against Foot-and-Mouth Disease Virus.设计针对口蹄疫病毒的功能多样、免疫原性高的基于肽的多表位疫苗。
Vaccines (Basel). 2020 Jul 22;8(3):406. doi: 10.3390/vaccines8030406.
3
Epitope-based vaccine as a universal vaccination strategy against infection: A mini-review.基于表位的疫苗作为预防感染的通用疫苗接种策略:一篇综述。
J Adv Vet Anim Res. 2019 Mar 24;6(2):174-182. doi: 10.5455/javar.2019.f329. eCollection 2019 Jun.
4
Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures-An Indian Perspective.口蹄疫病毒:免疫生物学、疫苗进展以及应对疫苗失效的疫苗接种策略——印度视角
Vaccines (Basel). 2019 Aug 16;7(3):90. doi: 10.3390/vaccines7030090.
5
Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.中空介孔硅纳米颗粒作为口蹄疫病毒样颗粒的递送载体可在豚鼠中诱导持久的免疫应答。
J Med Virol. 2019 Jun;91(6):941-948. doi: 10.1002/jmv.25417. Epub 2019 Feb 20.
6
Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.大肠杆菌中 SUMO 融合蛋白系统产生的口蹄疫病毒样颗粒在豚鼠、猪和牛中诱导强烈的保护性免疫应答。
Vet Res. 2013 Jul 4;44(1):48. doi: 10.1186/1297-9716-44-48.

本文引用的文献

1
Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.有望用于猪的抗O型口蹄疫病毒的多表位重组疫苗。
Clin Vaccine Immunol. 2011 Jan;18(1):143-9. doi: 10.1128/CVI.00236-10. Epub 2010 Nov 17.
2
A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle.一种用于更好地区分感染牛和接种疫苗牛的重组截短口蹄疫病毒 3AB 蛋白。
Vaccine. 2010 Apr 26;28(19):3435-9. doi: 10.1016/j.vaccine.2010.02.072. Epub 2010 Mar 1.
3
Foot and mouth disease virus vaccines.口蹄疫病毒疫苗
Vaccine. 2009 Nov 5;27 Suppl 4:D90-4. doi: 10.1016/j.vaccine.2009.08.039.
4
Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes.口蹄疫病毒来源的牛T细胞表位的主要组织相容性复合体限制性及锚定残基的鉴定
J Virol. 2009 May;83(9):4039-50. doi: 10.1128/JVI.01534-08. Epub 2009 Feb 11.
5
Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice.口蹄疫病毒免疫显性表位和热休克蛋白70在毕赤酵母中的异源表达及随后在小鼠体内引发的免疫反应。
Vet Microbiol. 2007 Oct 6;124(3-4):256-63. doi: 10.1016/j.vetmic.2007.04.030. Epub 2007 Apr 27.
6
Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.针对口蹄疫病毒的疫苗接种在7天内可提供完全的临床保护,在4天内可提供部分保护:用于紧急疫情应对。
Vaccine. 2005 Dec 30;23(50):5775-82. doi: 10.1016/j.vaccine.2005.07.043. Epub 2005 Aug 8.
7
Natural and vaccine induced immunity to FMD.针对口蹄疫的天然免疫和疫苗诱导免疫。
Curr Top Microbiol Immunol. 2005;288:103-31. doi: 10.1007/3-540-27109-0_5.
8
Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig.针对O/A型口蹄疫病毒感染的重组二价疫苗在豚鼠中的应用
Acta Biochim Biophys Sin (Shanghai). 2004 Sep;36(9):589-96. doi: 10.1093/abbs/36.9.589.
9
Foot-and-mouth disease.口蹄疫
Clin Microbiol Rev. 2004 Apr;17(2):465-93. doi: 10.1128/CMR.17.2.465-493.2004.
10
A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge.一种包含O型口蹄疫病毒VP1的G-H环区域共有序列和一个通用T辅助表位的合成肽可诱导产生肽特异性抗体,但无法保护牛免受病毒攻击。
Vaccine. 2003 Sep 8;21(25-26):3751-6. doi: 10.1016/s0264-410x(03)00364-5.